CG

Charmaine Gittleson

Percheron Therapeutics Limited | Executive Chairman, Executive Director
Dr Gittleson has international experience as a pharmaceutical physician and enterprise leader in pharmaceutical drug development, governance and risk management gained during her 15 years of tenure with global specialty biotechnology company CSL Limited. During her time at CSL, Charmaine had at various times accountability for clinical research, medical safety, medical and patient related ethics for development and on market programs, providing leadership in strategic product development, planning and implementation across multiple therapeutic and rare disease areas. She is also a member of Governance Committee.

Companies and Roles

Company
Title
Tenure
Since
PER
PER
Percheron Therapeutics Limited
  • Executive Chairman
  • Executive Director
4yrs, 2mthMar 2021
PAB
PAB
Patrys Limited
  • Non-Executive Chairman
  • Non-Executive Director
2yrs, 6mthNov 2022

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
PER
PER
Percheron Therapeutics Limited
20/05/2502,399,9993,239,999N/A
PAB
PAB
Patrys Limited
23/08/24N/AN/A8,000,000N/A
ANP
ANP
29/11/230733,3333,006,667N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
PER
PER
Percheron Therapeutics Limited
20/05/25
Issued
239,999$0.035$8,399Issue of options
PER
PER
Percheron Therapeutics Limited
31/12/24
Buy
1,666,666$0.009$14,999On-market trade
PER
PER
Percheron Therapeutics Limited
20/12/24
Expiry
6,667$0.007$46Options expired
ANP
ANP
29/11/23
Issued
3,000,000$0.060$180,000Issue of options
PER
PER
Percheron Therapeutics Limited
29/11/23
Issued
3,000,000$0.060$180,000Issue of options